Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001021408-03-000692
Filing Date
2003-01-28
Accepted
2003-01-28 14:21:49
Documents
3
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 202772
3 CEO CERTIFICATION dex991.htm EX-99.1 3356
4 CFO CERTIFICATION dex992.htm EX-99.2 3421
  Complete submission text file 0001021408-03-000692.txt   211426
Mailing Address PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-27410 | Film No.: 03527590
SIC: 2834 Pharmaceutical Preparations